![Selective estrogen receptor modulators / Eli Lilly and Company / Aromatase inhibitors / Alkenes / Bexarotene / Tamoxifen / Metastatic breast cancer / Breast cancer / Hormonal therapy / Chemistry / Medicine / Pharmacology Selective estrogen receptor modulators / Eli Lilly and Company / Aromatase inhibitors / Alkenes / Bexarotene / Tamoxifen / Metastatic breast cancer / Breast cancer / Hormonal therapy / Chemistry / Medicine / Pharmacology](https://www.pdfsearch.io/img/c8249ae9b8e1c2c09c4ce3035a07f979.jpg) Selective estrogen receptor modulators Eli Lilly and Company Aromatase inhibitors Alkenes Bexarotene Tamoxifen Metastatic breast cancer Breast cancer Hormonal therapy Chemistry Medicine Pharmacology | | Multicenter Phase II Study of Oral Bexarotene for Patients With Metastatic Breast Cancer By Francisco J. Esteva, John Glaspy, Said Baidas, Leslie Laufman, Laura Hutchins, Maura Dickler, Debu Tripathy, Roger Cohen,Add to Reading ListSource URL: jco.ascopubs.orgDownload Document from Source Website File Size: 284,11 KBShare Document on Facebook
|